GSK Consumer Healthcare has closed its transaction with Pfizer Consumer Healthcare in the UK and Ireland, creating a new joint venture under the name GSK Consumer Healthcare.

Launched on 27th April 2020, the business, led by Area General Manager Jon Workman, has spent the intervening period working to bring together the two legacy teams and establish GSK Consumer Healthcare as a single operational entity.

The joint venture brings together an array of fantastic brands including Sensodyne, Voltarol, Panadol, Corsodyl, Anadin, Centrum and Nexium. The combined portfolio means GSK strengthens its leading positions in pain relief, respiratory, vitamins, minerals and supplements, and therapeutic oral health categories and cements the company’s position as the world’s number one OTC business.

“The new GSK Consumer Healthcare company brings together the very best of both legacy businesses, delivering global leadership across a broad spectrum of therapeutic areas,” Workman said.

“We are committed to leveraging these strengths to provide the best service to our retail partners and further support our commitment to helping consumers take more control of their health, particularly as we come out of the other side of this pandemic.

“We are embarking on a long-term self-care movement with the aim of sustaining a shift in the behaviours of the nation – getting people to think pharmacist first and avoid unnecessary visits to the GP and A&E in the longer term.

“We have reviewed our organisational structures to create a new leadership team, including the appointment of Jon Lewis, previously of Pfizer, as GSK Consumer Healthcare’s new UK Sales Director."

Jon is joined by Jo Cooper, who has been appointed as Commercial Excellence Director, setting sales and innovation strategy and working to deliver best in class results for retailers.

“We look forward to continuing to work with our retail partners, as the new GSK Consumer Healthcare, to achieve our collective goals in 2020 and beyond. We firmly believe that our new expanded portfolio of brands plays an important role to consumers, especially in this present climate, and we are committed to leveraging these strengths to provide the best service to our retail partners.”

Visit www.GSK.com